| 臺北醫學大學 |
2004 |
生技製藥領域政策之現況與未來趨勢
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2004 |
Public Education on Rational Drug Use
|
王惠珀; Wang HP; Hsiu MM |
| 臺北醫學大學 |
2004 |
Introduction of APEC NPRS
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2004 |
Pharmaceutical regulation of biotech product toward international harmonization
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2004 |
EU-Taiwan technical cooperation program on medical devices
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2004 |
Pharmaceutical Regulation Toward global Harmonization
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2004 |
IND & NDA
|
王惠珀; Wang HP |
| 國立臺灣大學 |
2004 |
Unsualy sonographic appearance of a gastrointestinal stromal tumor presenting as a large multilocular cystic mass
|
Chang, CY; Wang, HP; Mao, TL; Hu, RH; Yang, PM; Lai, MY; Lin, JT |
| 臺北醫學大學 |
2003 |
D-Phenylglycine-L-Dopa as an Intrinsic Slow Dopamine-releasing Prodrug
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2003 |
Clinical trials in Taiwan: Regulatory achievements and current status
|
王惠珀; Wang HP; Chen SY |
| 臺北醫學大學 |
2003 |
International cooperation of Chinese Taipei
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2003 |
Good Manufacturing Practices in Taiwan
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2003 |
Strategy for global harmanization on pharmaceutical regulation
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2003 |
Integration of western and traditional Chinese medicine – The possibility of drug innovation
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2003 |
Integration of western and traditional Chinese medicine – The possibility of drug innovation
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2003 |
Drug insurance system in Taiwan : How It Affects the Community Pharmacy Practice
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2003 |
The Drug Injury Relief System in Taiwan
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2003 |
Promoting Integrated Medical Services through Community Education
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2003 |
International cooperation of Chinese Taipei
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2003 |
Good Manufacturing Practices in Taiwan
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2003 |
Strategy for global harmanization on pharmaceutical regulation
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2003 |
Integration of western and traditional Chinese medicine – The possibility of drug innovation
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2003 |
Integration of western and traditional Chinese medicine – The possibility of drug innovation
|
王惠珀; Wang HP |
| 國立高雄第一科技大學 |
2002.04 |
Speciation of copper in the incineration fly ash of a municipal solid waste
|
Hsiao, MC;Wang, HP;Wei, YL;Chang, JE;Jou, CJ. |
| 國立臺灣大學 |
2002-12 |
Correlation between serum levels of interleukin-6 and vascular endothelial growth factor in gastric carcinoma.
|
Huang, SP; Wu, MS; Wang, HP; Yang, CS; Kuo, ML; Lin, JT. |
| 臺北醫學大學 |
2002 |
A method in preparation of b-lactam antibiotics
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2002 |
Cardiac glycosides induced resistance to tubulin-dependent anticancer drugs in androgen-independent human prostate cancer
|
王惠珀; Hung DM; Guh JH; Huang YT; Chueh SC; Wang HP; Teng CM |
| 臺北醫學大學 |
2002 |
Pharmaceutical regulatory update
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2002 |
Integration of TCM into Western Medical Practice, Symposium on Chinese Herbal Medicine
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2002 |
Novel Lipophilc Folate Antimetabolites as Anticancer Agents for Brain Tumor
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2002 |
Preparation and Intestinal Absorption of L-Dopa-D-phenylglycine
|
王惠珀; Wang HP; Fang YB; Lu HH; Hsu WL |
| 臺北醫學大學 |
2002 |
Pharmaceutical regulatory update
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2002 |
Integration of TCM into Western Medical Practice, Symposium on Chinese Herbal Medicine
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2002 |
Recent developments of TCM in Taiwan
|
王惠珀; Wang HP |
| 高雄醫學大學 |
2002 |
Volatile organic compound emissions during Cold-Starts of Motorcycles
|
Wang, HC;Wang, HP;Oeng, CY;劉慧俐 |
| 高雄醫學大學 |
2002 |
Volatile organic compound emissions during Cold-Starts of Motorcycle
|
Wang, HC;Wang, HP;Oeng, CY;劉慧俐 |
| 國立臺灣大學 |
2002 |
A multiple logistic regression analysis of risk factors in different subtypes of gastric ulcer
|
Chen, MH; Wu, MS; Lee, WC; Wang, HP; Lin, JT |
| 中國醫藥大學 |
2002 |
Inhibition of lipopolysaccharide-stimulated nitric oxide production in RAW 264.7 macrophages by a synthetic carbazole, LCY-2-CHO
|
Tsao, LT; Lee, CY; Huang, LJ; Kuo, SC; Wang, HP |
| 臺北醫學大學 |
2001 |
Component analysis on black ant (Polyrhchis lamellidens) extracts from supercritical fluid extrction
|
王惠珀; Cheng YD; Tseng CH; Wang HP; Liao CC |
| 臺北醫學大學 |
2001 |
Optimization of drug in vivo activity via pharmacokinetic studies.
|
王惠珀; Wang HP |
| 臺北醫學大學 |
2001 |
用於治療巴金森氏症之新穎二及三胜 太仿擬化合物
|
王惠珀; Wang HP; Lee JS; Tsai MC; Lu HHHu OYP; Lo WL |
| 臺北醫學大學 |
2001 |
Optimization of drug in vivo activity via pharmacokinetic studies.
|
王惠珀; Wang HP |
| 國立臺灣大學 |
2000-12 |
Preparation and antitumor activities of beta-azatyrosinamides.
|
Wang, HP; Wu, MF; Shew, JY; Lee, O; Lee, SJ; Sung, CH. |
| 臺北醫學大學 |
2000 |
Neue Azatyrosin-Analogs and the process of preparation thereof.
|
王惠珀; Wang HP; Lee On; Shew JY; Lee SJ |
| 臺北醫學大學 |
2000 |
Preparation and antitumor activities of b-azatyrosinamides.
|
王惠珀; Wang HP; Wu MF; Shu CY; Lee O; Lee SJ; Sung CH |
| 臺北醫學大學 |
2000 |
D-Phenylglycine-L-dopa as slow-release prodrug of dopamine.
|
王惠珀; Wang HP |
| 臺北醫學大學 |
1999 |
Drug Delivery Through Dipeptide Transporter (I): Anti-Parkinsonism Effect of D-Phenylglycine-L-dopa and L-Dopa-D-Phenylglycine after Oral Administration.
|
王惠珀; Wang HP |
| 臺北醫學大學 |
1999 |
Aminoacyl Antraquinones as potential antineoplastic agents.
|
王惠珀; Lee O; LeeLT; Wu HS; Wang HP |
| 臺北醫學大學 |
1999 |
Selective cytotoxicity of novel Azatyrosinamides.
|
王惠珀; Lee O; Li YI; Hwang CF; Wang HP |
| 臺北醫學大學 |
1999 |
b-Azatyrosinamides: Synthesis and Selective cytotoxicity
|
王惠珀; Lee O; Wang HP |
